HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
CCTCC Cat# GDC0009, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
CCTCC |
GDC0009 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
Cellosaurus |
2026-11-14 04:01:01 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
NCBI_Iran Cat# C115, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
NCBI_Iran |
C115 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
Cellosaurus |
2026-11-14 04:01:01 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
DSMZ Cat# ACC-57, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
DSMZ |
ACC-57 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
Cellosaurus |
2026-11-14 04:01:01 |
39236 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
IZSLER Cat# BS TCL 23, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
IZSLER |
BS TCL 23 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
ATCC Cat# CCL-23, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
ATCC |
CCL-23 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
ECACC Cat# 86030501, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
ECACC |
86030501 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
KCLB Cat# 10023, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
KCLB |
10023 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
CCLV Cat# CCLV-RIE 0141, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
CCLV |
CCLV-RIE 0141 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
BCRC Cat# 60042, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
BCRC |
60042 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
BCRJ Cat# 0101, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
BCRJ |
0101 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
CCTCC Cat# GDC0004, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
CCTCC |
GDC0004 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
Cellosaurus |
2026-11-14 04:01:07 |
2898 |
HEY
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0297
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3731068 PMID:4016745 PMID:12960427 PMID:19926575 PMID:20204287 PMID:22710073 PMID:23415752 PMID:24023729 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Female |
Hey |
|
|
BTO:BTO_0002590, EFO:EFO_0006580, MCCL:MCC:0000188, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:866, BioSample:SAMN03473280, cancercelllines:CVCL_0297, Cell_Model_Passport:SIDM00968, ChEMBL-Cells:CHEMBL3308082, ChEMBL-Targets:CHEMBL613869, CLS:305017, Cosmic:1102812, Cosmic:1524358, Cosmic-CLP:1479988, DepMap:ACH-002140, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1479988, GEO:GSM659377, GEO:GSM1340581, GEO:GSM1669880, IARC_TP53:28489, PharmacoDB:HEY_541_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_0297, Wikidata:Q54883211 |
cvcl_4995 |
|
CVCL_0297 |
Cellosaurus |
2026-11-14 04:01:18 |
23 |
DK-MG
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-277, RRID:CVCL_1173
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:20215515 PMID:22460905 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
DKMG |
DSMZ |
ACC-277 |
CLO:CLO_0002782, EFO:EFO_0002161, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:857, BioSample:SAMN03470927, BioSample:SAMN10988036, cancercelllines:CVCL_1173, Cell_Model_Passport:SIDM00947, ChEMBL-Cells:CHEMBL3308814, ChEMBL-Targets:CHEMBL1075433, Cosmic:687566, Cosmic:906839, Cosmic:2302329, Cosmic:2367524, Cosmic:2516016, Cosmic-CLP:906839, DepMap:ACH-000244, DSMZ:ACC-277, DSMZCellDive:ACC-277, EGA:EGAS00001000978, GDSC:906839, GEO:GSM326231, GEO:GSM886978, GEO:GSM888047, GEO:GSM1669734, IARC_TP53:21303, IGRhCellID:DKMG, LiGeA:CCLE_375, LINCS_LDP:LCL-1350, PharmacoDB:DKMG_293_2019, PRIDE:PXD030304, Progenetix:CVCL_1173, PubChem_Cell_line:CVCL_1173, Wikidata:Q54831108 |
|
|
CVCL_1173 |
Cellosaurus |
2026-11-14 03:51:20 |
3 |
DMS 53
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1177
|
Homo sapiens (Human)
|
Lung small cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2986244 PMID:6266631 PMID:9744504 PMID:12712436 PMID:15016488 PMID:17426248 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27247353 PMID:27397505 PMID:28766886 PMID:30894373 PMID:31068700 PMID:32586373 PMID:35839778
|
Cancer cell line
|
Male |
DMS-53, DMS53, Darmouth Medical School 53 |
|
|
BTO:BTO_0005668, CLO:CLO_0002799, EFO:EFO_0002165, CLDB:cl1081, AddexBio:C0016027/4988, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2062, BioSample:SAMN03472957, BioSample:SAMN10987596, cancercelllines:CVCL_1177, Cell_Model_Passport:SIDM00523, ChEMBL-Cells:CHEMBL3308726, ChEMBL-Targets:CHEMBL1075434, Cosmic:907295, Cosmic:1995386, Cosmic:2125221, Cosmic:2648008, Cosmic-CLP:907295, DepMap:ACH-000698, ECACC:95062823, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907295, GEO:GSM17307, GEO:GSM169436, GEO:GSM170721, GEO:GSM170722, GEO:GSM886984, GEO:GSM888053, GEO:GSM1669737, GEO:GSM1887955, GEO:GSM1888032, IARC_TP53:21308, IGRhCellID:DMS53, LiGeA:CCLE_721, LINCS_LDP:LCL-1808, PharmacoDB:DMS53_300_2019, PRIDE:PXD011896, PRIDE:PXD030304, Progenetix:CVCL_1177, PubChem_Cell_line:CVCL_1177, Wikidata:Q54831310 |
|
|
CVCL_1177 |
Cellosaurus |
2026-11-14 03:51:23 |
12 |
DOK
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1180
|
Homo sapiens (Human)
|
Oral epithelial dysplasia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1459732 PMID:7917902 PMID:20164919 PMID:20215515 PMID:25169794 PMID:25485619 PMID:25877200 PMID:26234610 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Male |
Dysplastic Oral Keratinocyte |
|
|
CLO:CLO_0002806, EFO:EFO_0006564, CLDB:cl1087, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:858, BioSample:SAMN03473147, cancercelllines:CVCL_1180, CancerTools:153251, Cell_Model_Passport:SIDM00540, ChEMBL-Cells:CHEMBL3308727, ChEMBL-Targets:CHEMBL1075435, Cosmic:910936, Cosmic:1339915, Cosmic-CLP:910936, DepMap:ACH-002234, ECACC:94122104, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910936, GEO:GSM827453, GEO:GSM1374468, GEO:GSM1431134, GEO:GSM1669741, IARC_TP53:21311, PharmacoDB:DOK_304_2019, PRIDE:PXD030304, Progenetix:CVCL_1180, PubChem_Cell_line:CVCL_1180, Wikidata:Q54831351, Ximbio:153251 |
|
|
CVCL_1180 |
Cellosaurus |
2026-11-14 03:51:24 |
8 |
DMS 273
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1176
|
Homo sapiens (Human)
|
Lung small cell carcinoma
|
Population: Caucasian., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050 PMID:2986244 PMID:3335022 PMID:9212023 PMID:9744504 PMID:12712436 PMID:15900046 PMID:20164919 PMID:20215515 PMID:22336246 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27247353 PMID:27397505 PMID:28766886 PMID:30894373 PMID:31068700 PMID:31978347 PMID:32586373 PMID:35839778
|
Cancer cell line
|
Female |
DMS-273, DMS273, Darmouth Medical School 273 |
|
|
BTO:BTO_0005903, CLO:CLO_0002797, EFO:EFO_0002164, CLDB:cl1079, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472955, BioSample:SAMN10987982, cancercelllines:CVCL_1176, Cell_Model_Passport:SIDM00522, ChEMBL-Cells:CHEMBL3308487, ChEMBL-Targets:CHEMBL614034, Cosmic:687985, Cosmic:1436015, Cosmic:1609521, Cosmic:2125191, Cosmic:2648003, Cosmic-CLP:687985, DepMap:ACH-000749, ECACC:95062830, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:687985, GEO:GSM827419, GEO:GSM886982, GEO:GSM888051, GEO:GSM1669736, GEO:GSM1887904, GEO:GSM1887987, IARC_TP53:21307, IGRhCellID:DMS273, LiGeA:CCLE_304, LINCS_LDP:LCL-1807, PharmacoDB:DMS273_299_2019, PRIDE:PXD030304, Progenetix:CVCL_1176, PubChem_Cell_line:CVCL_1176, Wikidata:Q54831301 |
|
|
CVCL_1176 |
Cellosaurus |
2026-11-14 03:51:23 |
5 |
DoHH2
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1179
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Caution: A TP53 mutation is indicated as being at p.Ala138Pro (c.412G>C) in PubMed=17363600 but has not been confirmed by CCLE and Cosmic-CLP., Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, immunoblastic-type., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1849602 PMID:7849311 PMID:8057678 PMID:8558920 PMID:16960149 PMID:17363600 PMID:17495976 PMID:20164919 PMID:20215515 PMID:20454443 PMID:22460905 PMID:23699601 PMID:25355872 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:26727417 PMID:27397505 PMID:28196595 PMID:30165192 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
DOHH2, DoHH-2, DOHH-2 |
|
|
CLO:CLO_0002805, CLO:CLO_0037050, EFO:EFO_0002167, CLDB:cl1086, CLDB:cl4974, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03472093, BioSample:SAMN10988489, cancercelllines:CVCL_1179, Cell_Model_Passport:SIDM00981, ChEMBL-Cells:CHEMBL3308537, ChEMBL-Targets:CHEMBL2366181, Cosmic:906842, Cosmic:1086332, Cosmic:1629929, Cosmic:1995387, Cosmic:2297004, Cosmic:2437317, Cosmic-CLP:906842, DepMap:ACH-000056, DSMZ:ACC-47, DSMZCellDive:ACC-47, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, ENCODE:ENCBS100ZVH, ENCODE:ENCBS652PBR, ENCODE:ENCBS662OGM, ENCODE:ENCBS898JGF, GDSC:906842, GEO:GSM115817, GEO:GSM179646, GEO:GSM201345, GEO:GSM886987, GEO:GSM888056, GEO:GSM1035327, GEO:GSM1374467, GEO:GSM1527310, GEO:GSM1527311, GEO:GSM1527312, GEO:GSM1527313, GEO:GSM1527314, GEO:GSM1527315, GEO:GSM1669740, IARC_TP53:21310, IARC_TP53:25029, ICLC:HTL99022, IGRhCellID:DOHH2, IZSLER:BS TCL 228, LiGeA:CCLE_934, LINCS_LDP:LCL-1143, Lonza:666, PharmacoDB:DOHH2_303_2019, PRIDE:PXD030304, Progenetix:CVCL_1179, PubChem_Cell_line:CVCL_1179, Wikidata:Q54831350 |
|
|
CVCL_1179 |
Cellosaurus |
2026-11-14 03:51:24 |
25 |
DMS 79
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1178
|
Homo sapiens (Human)
|
Lung small cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2986244 PMID:6266631 PMID:8383976 PMID:9744504 PMID:12712436 PMID:15016488 PMID:17426248 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27247353 PMID:27397505 PMID:28196595 PMID:28766886 PMID:30894373 PMID:31068700 PMID:32586373 PMID:35839778
|
Cancer cell line
|
Male |
DMS-79, DMS79, Darmouth Medical School 79 |
|
|
CLO:CLO_0002800, CLO:CLO_0002802, EFO:EFO_0002166, CLDB:cl1082, CLDB:cl4907, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2049, BioSample:SAMN03473247, BioSample:SAMN10988337, cancercelllines:CVCL_1178, Cell_Model_Passport:SIDM00524, ChEMBL-Cells:CHEMBL3307581, ChEMBL-Targets:CHEMBL614286, CLS:300164, Cosmic:753551, Cosmic:1609526, Cosmic:2648007, Cosmic-CLP:753551, DepMap:ACH-000703, ECACC:95062824, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:753551, GEO:GSM17308, GEO:GSM169445, GEO:GSM886985, GEO:GSM888054, GEO:GSM1669738, GEO:GSM1887956, GEO:GSM1888033, IARC_TP53:21309, ICLC:HTL98009, IGRhCellID:DMS79, LiGeA:CCLE_666, LINCS_LDP:LCL-1832, PharmacoDB:DMS79_301_2019, PRIDE:PXD011896, PRIDE:PXD030304, Progenetix:CVCL_1178, PubChem_Cell_line:CVCL_1178, Wikidata:Q54831312 |
|
|
CVCL_1178 |
Cellosaurus |
2026-11-14 03:51:23 |
7 |
DV-90
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1184
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7839470 PMID:10908148 PMID:20164919 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26361996 PMID:26589293 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
DV90 |
|
|
CLO:CLO_0002847, EFO:EFO_0006565, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioSample:SAMN03473076, BioSample:SAMN10988133, cancercelllines:CVCL_1184, Cell_Model_Passport:SIDM01510, ChEMBL-Cells:CHEMBL3308729, ChEMBL-Targets:CHEMBL1075437, Cosmic:753553, Cosmic:1146951, DepMap:ACH-000925, DSMZ:ACC-307, DSMZCellDive:ACC-307, EGA:EGAS00001000610, GDSC:753553, GEO:GSM434301, GEO:GSM784284, GEO:GSM886990, GEO:GSM888059, IARC_TP53:21313, IGRhCellID:DV-90_02GEO, LiGeA:CCLE_820, LINCS_LDP:LCL-1636, PharmacoDB:DV90_311_2019, PRIDE:PXD002556, Progenetix:CVCL_1184, PubChem_Cell_line:CVCL_1184, Wikidata:Q54831597 |
|
|
CVCL_1184 |
Cellosaurus |
2026-11-14 03:51:30 |
3 |
EB2 [Human Burkitt lymphoma]
Resource Report
Resource Website
|
RRID:CVCL_1186
|
Homo sapiens (Human)
|
EBV-related Burkitt lymphoma
|
Population: African; Ugandan., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2998993 PMID:3518877 PMID:4736620 PMID:4894370 PMID:5884338 PMID:6018567 PMID:7316467 PMID:8515068 PMID:14284371 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
EB-2, Epstein-Barr-2 |
|
|
CLO:CLO_0002873, EFO:EFO_0002173, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:HTB-61, BioSample:SAMN10987938, cancercelllines:CVCL_1186, Cell_Model_Passport:SIDM00863, ChEMBL-Cells:CHEMBL3308867, ChEMBL-Targets:CHEMBL2366338, Cosmic:906846, Cosmic:1818342, Cosmic-CLP:906846, DepMap:ACH-001064, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906846, GEO:GSM886992, GEO:GSM888061, GEO:GSM1669747, IARC_TP53:21316, IGRhCellID:EB2, LINCS_LDP:LCL-2031, PharmacoDB:EB2_314_2019, PRIDE:PXD030304, Progenetix:CVCL_1186, PubChem_Cell_line:CVCL_1186, Wikidata:Q54831747 |
|
|
CVCL_1186 |
Cellosaurus |
2026-11-14 03:51:34 |
0 |